Recursion Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $7.8M | 1.2M | 6.59 |
| 2024-06-30 | $8.3M | 1.1M | 7.50 |
| 2024-03-31 | $11M | 1.1M | 9.97 |
| 2023-12-31 | $3.8M | 381k | 9.86 |
| 2023-09-30 | $7.3M | 955k | 7.65 |
| 2023-06-30 | $2.8M | 375k | 7.47 |
| 2023-03-31 | $2.1M | 310k | 6.68 |
| 2022-12-31 | $1.3M | 173k | 7.75 |
| 2022-06-30 | $1.4M | 169k | 8.17 |
| 2022-03-31 | $909k | 127k | 7.15 |
| 2021-12-31 | $2.7M | 156k | 17.14 |